Bosen You

1.0k total citations
30 papers, 688 citations indexed

About

Bosen You is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Bosen You has authored 30 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Bosen You's work include Prostate Cancer Treatment and Research (10 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (8 papers). Bosen You is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (8 papers). Bosen You collaborates with scholars based in China, Taiwan and United States. Bosen You's co-authors include Chawnshang Chang, Chi‐Ping Huang, Yin Sun, Shuyuan Yeh, Xuedong Li, Fu-Ju Chou, Wanhai Xu, Ronghao Wang, Jialin Meng and Guanglu Dong and has published in prestigious journals such as Nature Communications, Oncogene and Cell Death and Differentiation.

In The Last Decade

Bosen You

29 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bosen You China 16 481 302 190 99 80 30 688
Yangjia Zhuo China 16 436 0.9× 282 0.9× 185 1.0× 92 0.9× 53 0.7× 44 674
Hongle Li China 16 421 0.9× 267 0.9× 191 1.0× 220 2.2× 74 0.9× 44 724
Junjie Cen China 15 470 1.0× 341 1.1× 136 0.7× 94 0.9× 55 0.7× 31 647
Xiulan Zheng China 13 397 0.8× 308 1.0× 276 1.5× 148 1.5× 67 0.8× 14 637
Huafu Li China 10 401 0.8× 252 0.8× 104 0.5× 110 1.1× 56 0.7× 18 595
Elisabeth Smolle Austria 12 329 0.7× 237 0.8× 154 0.8× 146 1.5× 47 0.6× 21 639
Yimeng Song China 14 436 0.9× 283 0.9× 284 1.5× 85 0.9× 57 0.7× 42 683
Ryan W. Askeland United States 15 486 1.0× 307 1.0× 87 0.5× 160 1.6× 51 0.6× 29 771
Zhongyin Yang China 14 318 0.7× 174 0.6× 198 1.0× 152 1.5× 77 1.0× 39 612

Countries citing papers authored by Bosen You

Since Specialization
Citations

This map shows the geographic impact of Bosen You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bosen You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bosen You more than expected).

Fields of papers citing papers by Bosen You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bosen You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bosen You. The network helps show where Bosen You may publish in the future.

Co-authorship network of co-authors of Bosen You

This figure shows the co-authorship network connecting the top 25 collaborators of Bosen You. A scholar is included among the top collaborators of Bosen You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bosen You. Bosen You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Bo, Weiyang Liu, Wan‐Hui Wang, et al.. (2025). CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysis. Frontiers in Immunology. 16. 1619361–1619361.
2.
Liu, Qing, Jinpeng Wang, Zhuolun Li, et al.. (2025). ERα-dependent crosstalk between macrophages and cancer cells potentiates vasculogenic mimicry and M2 macrophage polarization in bladder cancer. Cell Communication and Signaling. 23(1). 339–339. 1 indexed citations
3.
Liu, Qing, Hongyang Yu, Xinyang He, et al.. (2022). Tumor-associated macrophage-derived exosomes transmitting miR-193a-5p promote the progression of renal cell carcinoma via TIMP2-dependent vasculogenic mimicry. Cell Death and Disease. 13(4). 382–382. 52 indexed citations
4.
Liu, Qing, Bosen You, Jialin Meng, et al.. (2022). Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling. Cancer Gene Therapy. 29(12). 1988–2000. 36 indexed citations
5.
Guo, Chuanyong, Yin Sun, Wei Zhai, et al.. (2022). Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis. Cell & Bioscience. 12(1). 185–185. 8 indexed citations
6.
Li, Xuedong, et al.. (2022). Identification of a Five-miRNA Signature for Diagnosis of Kidney Renal Clear Cell Carcinoma. Frontiers in Genetics. 13. 857411–857411. 4 indexed citations
7.
Li, Jingquan, Fanghao Lu, Xin Shao, & Bosen You. (2022). Investigating the potential clinical significance of long non-coding RNA 00092 in patients with breast cancer. Annals of Translational Medicine. 10(10). 602–602. 4 indexed citations
8.
Xiang, Zhendong, Yin Sun, Bosen You, et al.. (2021). Suppressing BCL-XL increased the high dose androgens therapeutic effect to better induce the Enzalutamide-resistant prostate cancer autophagic cell death. Cell Death and Disease. 12(1). 68–68. 13 indexed citations
9.
Li, Jingquan, et al.. (2021). 5-FU@DHA-UIO-66-NH2 potentiates chemotherapy sensitivity of breast cancer cells through a microRNA let-7a-dependent mechanism. Annals of Translational Medicine. 9(24). 1761–1761. 13 indexed citations
10.
You, Bosen, Yin Sun, Jie Luo, et al.. (2021). Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR. Oncogene. 40(9). 1674–1689. 42 indexed citations
11.
Tian, Hao, Fu-Ju Chou, Jing Tian, et al.. (2021). ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling. Journal of Experimental & Clinical Cancer Research. 40(1). 3–3. 9 indexed citations
12.
Wu, Pengfei, Qun Chen, Jiang Liu, et al.. (2020). Tumor Cell–Derived TGFβ1 Attenuates Antitumor Immune Activity of T Cells via Regulation of PD-1 mRNA. Cancer Immunology Research. 8(12). 1470–1484. 35 indexed citations
13.
Wang, Keliang, Jie Luo, Shuyuan Yeh, et al.. (2020). The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer. Nature Communications. 11(1). 2689–2689. 52 indexed citations
14.
Chou, Fu-Ju, Yuhchyau Chen, Hao Tian, et al.. (2020). Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity. Cancer Letters. 495. 100–111. 27 indexed citations
15.
Liu, Guodong, Xiwu Ouyang, Yin Sun, et al.. (2020). The miR-92a-2-5p in exosomes from macrophages increases liver cancer cells invasion via altering the AR/PHLPP/p-AKT/β-catenin signaling. Cell Death and Differentiation. 27(12). 3258–3272. 74 indexed citations
16.
Chen, Jinbo, Yin Sun, Zhenyu Ou, et al.. (2020). Androgen receptor‐regulated circ FNTA activates KRAS signaling to promote bladder cancer invasion. EMBO Reports. 21(4). e48467–e48467. 71 indexed citations
17.
18.
Gu, Junfei, Yong Zhang, Zhenwei Han, et al.. (2020). Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC. Cell Death and Disease. 11(5). 367–367. 24 indexed citations
19.
Li, Lihong, et al.. (2019). Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma. Journal of Translational Medicine. 17(1). 177–177. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yangjia Zhuo Breakdown of academic impact, for papers by Hongle Li Breakdown of academic impact, for papers by Junjie Cen Breakdown of academic impact, for papers by Xiulan Zheng Breakdown of academic impact, for papers by Huafu Li Breakdown of academic impact, for papers by Elisabeth Smolle Breakdown of academic impact, for papers by Yimeng Song Breakdown of academic impact, for papers by Ryan W. Askeland Breakdown of academic impact, for papers by Zhongyin Yang
Rankless by CCL
2026